• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与纤维蛋白封闭剂相关的顽固性过敏反应:“组织胶切除术”治疗

Recalcitrant Anaphylaxis Associated with Fibrin Sealant: Treatment with "TISSEEL-ectomy".

作者信息

Saffarzadeh Mohammadali, Mulpuri Anvith, Arneja Jugpal S

机构信息

Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

St. George's School, Vancouver, BC, Canada.

出版信息

Plast Reconstr Surg Glob Open. 2021 Jan 22;9(1):e3382. doi: 10.1097/GOX.0000000000003382. eCollection 2021 Jan.

DOI:10.1097/GOX.0000000000003382
PMID:33552820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7862072/
Abstract

Here, we present the case of an adolescent male who developed a severe allergic reaction 10 minutes after application of TISSEEL fibrin sealant to control bleeding during a gynecomastia revision surgery. Conventional treatments of acute hypersensitivity were ineffective. After a "tisseel-ectomy," the patient's condition improved and symptoms resolved. Besides oral tranexamic acid, and topical and local anaesthesia, no other medications besides TISSEEL were administered preceding the allergic reaction. After TISSEEL was identified as the allergen upon its removal, his clinical status improved. The patient had been exposed to TISEEL 15 months before the anaphylactic episode. This case can aid in decision-making for surgical re-exposure to fibrin sealants in the setting of acute anaphylaxis.

摘要

在此,我们报告一例青春期男性病例,该患者在男性乳房肥大修复手术中应用TISSEEL纤维蛋白封闭剂控制出血10分钟后出现严重过敏反应。急性超敏反应的常规治疗无效。在进行“TISSEEL切除术”后,患者病情改善,症状缓解。除口服氨甲环酸以及局部外用和局部麻醉外,在过敏反应发生前,除TISSEEL外未使用其他药物。在移除TISSEEL后确定其为过敏原,患者的临床状况得到改善。该患者在过敏反应发作前15个月接触过TISSEEL。该病例有助于在急性过敏反应情况下决定是否再次进行手术暴露于纤维蛋白封闭剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/7862072/6c37b120aea4/gox-9-e3382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/7862072/77110b9be860/gox-9-e3382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/7862072/79385a2fb669/gox-9-e3382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/7862072/6c37b120aea4/gox-9-e3382-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/7862072/77110b9be860/gox-9-e3382-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/7862072/79385a2fb669/gox-9-e3382-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1d/7862072/6c37b120aea4/gox-9-e3382-g003.jpg

相似文献

1
Recalcitrant Anaphylaxis Associated with Fibrin Sealant: Treatment with "TISSEEL-ectomy".与纤维蛋白封闭剂相关的顽固性过敏反应:“组织胶切除术”治疗
Plast Reconstr Surg Glob Open. 2021 Jan 22;9(1):e3382. doi: 10.1097/GOX.0000000000003382. eCollection 2021 Jan.
2
Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel.与同源纤维蛋白密封剂产品Tissucol/Tisseel相比,CryoSeal和Vivostat生产的自体纤维蛋白密封剂的生化特性。
Biomaterials. 2005 Nov;26(31):6233-41. doi: 10.1016/j.biomaterials.2005.04.014.
3
An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty.含抑肽酶的纤维蛋白胶不能减少全髋关节置换术的失血量。
J Arthroplasty. 2017 Nov;32(11):3445-3448. doi: 10.1016/j.arth.2017.05.040. Epub 2017 May 31.
4
Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel.人腹膜间皮细胞、正常腹膜及粘连部位成纤维细胞中转化生长因子-β及细胞外基质的表达:纤维蛋白黏合剂的作用
Wound Repair Regen. 2004 Sep-Oct;12(5):557-64. doi: 10.1111/j.1067-1927.2004.012508.x.
5
Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.纤维蛋白黏合剂对组织型纤溶酶原激活物及纤溶酶原激活物抑制剂-1表达的影响
Fertil Steril. 2004 Jun;81(6):1657-64. doi: 10.1016/j.fertnstert.2003.12.022.
6
Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.在心脏手术患者中比较TISSEEL VH S/D纤维蛋白密封剂与目前已获许可的TISSEEL VH的局部止血疗效和安全性评估:一项3期随机双盲临床研究。
J Cardiovasc Surg (Torino). 2007 Jun;48(3):323-31.
7
Bleeding-Related Complications and Readmission Rates Associated With Fibrin Sealant Use in Patients Undergoing Coronary Artery Bypass Graft Surgery in the United States.美国冠状动脉搭桥手术患者使用纤维蛋白密封剂相关的出血并发症及再入院率
J Cardiothorac Vasc Anesth. 2017 Jun;31(3):876-882. doi: 10.1053/j.jvca.2016.11.015. Epub 2016 Nov 10.
8
Management of recurrent haemoptysis in malignancy with combined TISSEEL and intrabronchial valves.
Respirol Case Rep. 2019 Jan 31;7(3):e00406. doi: 10.1002/rcr2.406. eCollection 2019 Apr.
9
In vivo efficacy of a new autologous fibrin sealant.一种新型自体纤维蛋白密封剂的体内疗效
J Surg Res. 2008 May 1;146(1):143-8. doi: 10.1016/j.jss.2007.08.006. Epub 2007 Aug 31.
10
A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants.两种不同纤维蛋白密封剂形成的纤维蛋白凝块的力学、动力学和生化特性比较。
Blood Coagul Fibrinolysis. 2011 Jan;22(1):19-23. doi: 10.1097/MBC.0b013e32833fcbfb.

引用本文的文献

1
Anaphylaxis associated with Tisseel fibrin sealant during re-resection of a craniopharyngioma: illustrative case.颅咽管瘤再次切除术中与Tisseel纤维蛋白封闭剂相关的过敏反应:病例说明
J Neurosurg Case Lessons. 2025 Jun 2;9(22). doi: 10.3171/CASE2517.
2
Platelet rich fibrin and commercial sealants for dural closure in neurosurgery: An in vitro study.富血小板纤维蛋白与神经外科硬脑膜封闭用商业密封剂:一项体外研究。
PLoS One. 2025 Apr 1;20(4):e0319349. doi: 10.1371/journal.pone.0319349. eCollection 2025.
3
Leukocyte- and platelet-rich fibrin in endoscopic endonasal skull base reconstruction: study protocol for a multicenter prospective, parallel-group, single-blinded randomized controlled non-inferiority trial.

本文引用的文献

1
Recent developments and clinical applications of surgical glues: An overview.外科胶水的最新进展和临床应用:概述。
Int J Biol Macromol. 2019 Sep 15;137:95-106. doi: 10.1016/j.ijbiomac.2019.06.208. Epub 2019 Jun 27.
2
Bleeding-Related Complications and Readmission Rates Associated With Fibrin Sealant Use in Patients Undergoing Coronary Artery Bypass Graft Surgery in the United States.美国冠状动脉搭桥手术患者使用纤维蛋白密封剂相关的出血并发症及再入院率
J Cardiothorac Vasc Anesth. 2017 Jun;31(3):876-882. doi: 10.1053/j.jvca.2016.11.015. Epub 2016 Nov 10.
3
Multiple uses of fibrin sealant for nervous system treatment following injury and disease.
富含白细胞和血小板的纤维蛋白在鼻内镜颅底重建中的应用:一项多中心前瞻性、平行组、单盲、随机对照非劣效性临床试验研究方案。
Trials. 2023 Jul 31;24(1):488. doi: 10.1186/s13063-023-07492-w.
4
Bio-macromolecular design roadmap towards tough bioadhesives.生物大分子设计通向坚韧型生物胶粘剂的路线图。
Chem Soc Rev. 2022 Oct 31;51(21):9127-9173. doi: 10.1039/d2cs00618a.
5
Intraoperative anaphylaxis due to aprotinin after local application of fibrin sealant diagnosed by skin tests and basophil activation tests: a case report.通过皮肤试验和嗜碱性粒细胞活化试验诊断局部应用纤维蛋白封闭剂后因抑肽酶导致的术中过敏反应:一例报告
JA Clin Rep. 2021 Sep 8;7(1):68. doi: 10.1186/s40981-021-00472-6.
纤维蛋白密封剂在神经系统损伤和疾病治疗中的多种应用。
J Venom Anim Toxins Incl Trop Dis. 2017 Mar 14;23:13. doi: 10.1186/s40409-017-0103-1. eCollection 2017.
4
The current place of aprotinin in the management of bleeding.抑肽酶在出血管理中的当前位置。
Anaesthesia. 2015 Jan;70 Suppl 1:46-9, e17. doi: 10.1111/anae.12907.
5
Current state and use of biological adhesives in orthopedic surgery.生物粘合剂在骨科手术中的现状与应用
Orthopedics. 2013 Dec;36(12):945-56. doi: 10.3928/01477447-20131120-09.
6
Comparison of hemostatic agents used in vascular surgery.血管外科中使用的止血剂比较。
Expert Opin Biol Ther. 2013 Dec;13(12):1663-72. doi: 10.1517/14712598.2013.848193. Epub 2013 Oct 22.
7
A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat.抑肽酶-free 纤维蛋白封闭剂与可吸收止血剂的随机对照试验。
Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):572-7. doi: 10.1177/1076029611404212. Epub 2011 Aug 25.
8
Anaphylactic reactions to fibrin sealant injection for spontaneous spinal CSF leaks.自发性脊髓脑脊液漏注射纤维蛋白封闭剂后的过敏反应。
Neurology. 2008 Mar 11;70(11):885-7. doi: 10.1212/01.WNL.0000265400.54810.13. Epub 2007 Oct 3.
9
Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery.抑肽酶与过敏反应:对心脏手术中12403例抑肽酶暴露情况的分析
Ann Thorac Surg. 2007 Oct;84(4):1144-50. doi: 10.1016/j.athoracsur.2007.05.015.
10
Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions.临床使用抑肽酶四十年:124例过敏反应回顾
Ann Thorac Surg. 2005 Feb;79(2):741-8. doi: 10.1016/j.athoracsur.2004.03.072.